Autologous haematopoietic stem cell transplants for autoimmune disease - Feasibility and transplant-related mortality

Bone Marrow Transplantation

Volumn 24, Issue 7, 1999, Pages 729-734

  Tyndall, A ^a   Fassas, A ^b   Passweg, J ^b   Ruiz De Elvira, C ^b   Attal, M ^b   Brooks, P ^b   Black, C ^b   Durez, P ^b   Finke, J ^b   Forman, S ^b   Fouillard, L ^b   Furst, D ^b   Holmes, J A ^b   Joske, D ^b   Jouet, J P ^b   Kotter I ^b   Locatelli, F ^b   Prentice, H G ^b   Marmont, A M ^b   McSweeney, P ^b   Musso, M ^b   Peter, H H ^b   Snowden, J A ^b   Sullivan, K ^b   Tichelli, A ^b   Vavriec, J ^b   Wulffraat, N M ^b   Schmitz, N ^b   Gratwohl, A ^b   more..

^a Felix Platter Spital   (Switzerland)

^b NONE

Author keywords

Autoimmune disease; Bone marrow; Mortality; Stem cell; Toxicity

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY; MELPHALAN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; B LYMPHOCYTE; BLEEDING; BLOOD DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; RHEUMATIC DISEASE; SCHOOL CHILD; T LYMPHOCYTE; VASCULITIS;

EID: 0032836986     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701987     Document Type: Article

References (31)

1. Snowden JA, Brooks PM, Biggs JC. Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol 1997; 99: 9-22.
2. van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993; 11: 183-187.
3. Marmont AM. Stem cell transplantation for severe autoimmune disease: progress and problems. Haematologica 1998; 83: 733-744.
4. Ikehara S, Good RA, Nakamura T et al. Rationale for bone marrow transplantation in the treatment of autoimmune disease. Proc Natl Acad Sci USA 1985; 82: 2483-2487.
5. Tyndall A, Gratwohl A. Hematopoetic stem cell transplantation for autoimmune disease. In: Blume K, Forman S, Thomas ED (eds). Hematopoietic Cell Transplantation. Blackwell Science: 1999, pp 1117-1122.
6. Tyndall A, Gratwohl A. Microchimerism, friend or foe. Nature Med 1998; 4: 386-387.
7. Marmont A, Vischer V, Gratwohl A, Tyndall A. Haemopoietic precursor cell transplants for autoimmune disease. Lancet 1995; 345: 978.
8. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390-392.
9. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643-645.
10. Clift R, Goldman JM, Gratwohl A, Horowitz MM. Proposal for standardized reporting of results of bone marrow transplantation for leukemia. Bone Marrow Transplant 1989; 4: 445-448.
11. Kurtzke JF. Rating neurological impairement in multiple sclerosis: an expanded disability scale. Neurology 1983; 33: 1444-1452.
12. Giannini EH, Ruperto N, Ravelli A et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-1209.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958; 53: 457-481.
14. Greenwood M. The errors of sampling of the survivorship tables. Reports on Public Health and Statistical Subjects, 33: Appendix 1. HMSO: London, 1926.
15. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
16. Anderlini P, Korbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997; 90: 903-908.
17. Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis - first results from a pilot study. Bone Marrow Transplant 1997; 20: 631-638.
18. Burt RK et al. T cell depleted autologous hematopoietic transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998; 21: 537-541.
19. Tyndall A, Black C, Finke J et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997; 349: 254.
20. Tamm M, Gratwohl A, Tichelli A et al. Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. Ann Rheum Dis 1996; 55: 779-780.
21. Joske DJL, Ma DT, Langlands DR, Owen ET. Autologous bone marrow transplantation for rheumatoid arthritis. Lancet 1997; 350: 337.
22. Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem cell transplantation for systemic lupus erythematosus. New Engl J Med 1997; 337: 1777-1778.
23. Skoda RC, Tichelli A, Tyndall A et al. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. Br J Haematol 1997; 99: 56-57.
24. Lim SH, Kell J, Al-Sabah A et al. Peripheral blood stem cell transplantation for refractory autoimmune thrombocytopenic purpura (letter). Lancet 1997; 349: 475.
25. Mahendra P, Johnson D, Scott MA et al. Peripheral blood prognitor cell transplantation: a single centre experience. Bone Marrow Transplant 1996; 17: 503-507.
26. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827.
27. Gratwohl J, Hermans, Goldman JM et al for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation. Lancet 1998; 352: 1087-1092.
28. Tichelli A, Socié G, Henry-Amar M et al for the Working Party on Severe Aplastic Anemia of the EBMT. Ann Intern Med 1999; 130: 193-201.
29. Euler HH, Marmont AM, Bacigalupo A et al. Early recurrence of or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621-3625.
30. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey on the role of marrow purging. Blood 1990; 75: 1606-1614.
31. Rizzoli V, Carlo-Stella C. Stem cell manipulation: why and how performing peripheral blood progenitor cell purging. Crit Rev Oncol Haematol 1997; 26: 101-115.